Boston's Watchman set for H1 2014 US approval
This article was originally published in Clinica
Executive Summary
A US FDA advisory panel has voted overwhelmingly in favor of Boston Scientific’s Watchman stroke-prevention device for atrial fibrillation patients, paving the way for its approval in the first half of 2014.